Casein kinase II controls TBK1/IRF3 activation in IFN response against viral infection

Journal of Immunology

Volumn 194, Issue 9, 2015, Pages 4477-4488

  Du, Min ^a   Liu, Jinghua ^a   Chen, Xia ^a   Xie, Yadong ^a   Yuan, Chuanping ^a   Xiang, Yu ^b   Sun, Bing ^a   Lan, Ke ^b   Chen, Mingzhou ^c   James, Sharmy J ^d,e   Zhang, Yongliang ^d,e   Zhong, Jin ^b   Xiao, Hui ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c WUHAN UNIVERSITY   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; BETA INTERFERON; CASEIN KINASE II; INTERFERON REGULATORY FACTOR 3; PATTERN RECOGNITION RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE; RIG I LIKE RECEPTOR; STING PROTEIN; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; INTERFERON; MEMBRANE PROTEIN; MPYS PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; TBK1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DNA VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE EVASION; INTERFERON INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS; VIRUS REPLICATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DISEASE MODEL; GENETICS; HEPATITIS C; HERPES SIMPLEX; IMMUNOLOGY; METABOLISM; VIRUS INFECTION;

ANIMALS; CASEIN KINASE II; CELL LINE; DISEASE MODELS, ANIMAL; HEPATITIS C; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERONS; MEMBRANE PROTEINS; MICE; PROTEIN-SERINE-THREONINE KINASES; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; VIRUS DISEASES;

EID: 84928474101     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402777     Document Type: Article

References (69)

1. Cai, X., Y. H. Chiu, and Z. J. Chen. 2014. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54: 289-296.
2. Kawai, T., and S. Akira. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141: 137-145.
3. Meylan, E., and J. Tschopp. 2006. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22: 561-569.
4. Saito, T., and M. Gale, Jr. 2007. Principles of intracellular viral recognition. Curr. Opin. Immunol. 19: 17-23.
5. García-Sastre, A., and C. A. Biron. 2006. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 312: 879-882.
6. Iwasaki, A. 2012. Innate immune recognition of HIV-1. Immunity 37: 389-398.
7. Luban, J. 2012. Innate immune sensing of HIV-1 by dendritic cells. Cell Host Microbe 12: 408-418.
8. Thimme, R., V. Lohmann, and F. Weber. 2006. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res. 69: 129-141.
9. Manel, N., and D. R. Littman. 2011. Hiding in plain sight: how HIV evades innate immune responses. Cell 147: 271-274.
10. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
11. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6: 975-990.
12. Gao, D., J. Wu, Y. T. Wu, F. Du, C. Aroh, N. Yan, L. Sun, and Z. J. Chen. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341: 903-906.
13. Sun, L., J. Wu, F. Du, X. Chen, and Z. J. Chen. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786-791.
14. Unterholzner, L., S. E. Keating, M. Baran, K. A. Horan, S. B. Jensen, S. Sharma, C. M. Sirois, T. Jin, E. Latz, T. S. Xiao, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11: 997-1004.
15. Zhang, Z., B. Yuan, M. Bao, N. Lu, T. Kim, and Y. J. Liu. 2011. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12: 959-965.
16. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
17. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai, and H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727-740.
18. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988.
19. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
20. Chen, H., H. Sun, F. You, W. Sun, X. Zhou, L. Chen, J. Yang, Y. Wang, H. Tang, Y. Guan, et al. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147: 436-446.
21. Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
22. Sun, W., Y. Li, L. Chen, H. Chen, F. You, X. Zhou, Y. Zhou, Z. Zhai, D. Chen, and Z. Jiang. 2009. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. USA 106: 8653-8658.
23. Zhong, B., Y. Yang, S. Li, Y. Y. Wang, Y. Li, F. Diao, C. Lei, X. He, L. Zhang, P. Tien, and H. B. Shu. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29: 538-550.
24. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 1641-1650.
25. Clark, K., O. Takeuchi, S. Akira, and P. Cohen. 2011. The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 108: 17093-17098.
26. Zhao, W. 2013. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett. 587: 542-548.
27. Li, S., L. Wang, M. Berman, Y. Y. Kong, and M. E. Dorf. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35: 426-440.
28. Lei, C. Q., B. Zhong, Y. Zhang, J. Zhang, S. Wang, and H. B. Shu. 2010. Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33: 878-889.
29. Larabi, A., J. M. Devos, S. L. Ng, M. H. Nanao, A. Round, T. Maniatis, and D. Panne. 2013. Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Reports 3: 734-746.
30. Foka, P., A. Dimitriadis, E. Kyratzopoulou, D. A. Giannimaras, S. Sarno, G. Simos, U. Georgopoulou, and A. Mamalaki. 2014. A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression. Cell. Mol. Life Sci. 71: 4243-4258.
31. Zhao, T., L. Yang, Q. Sun, M. Arguello, D. W. Ballard, J. Hiscott, and R. Lin. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8: 592-600.
32. Wang, C., T. Chen, J. Zhang, M. Yang, N. Li, X. Xu, and X. Cao. 2009. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat. Immunol. 10: 744-752.
33. Tu, D., Z. Zhu, A. Y. Zhou, C. H. Yun, K. E. Lee, A. V. Toms, Y. Li, G. P. Dunn, E. Chan, T. Thai, et al. 2013. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Reports 3: 747-758.
34. Sharma, K., C. Kumar, G. Kéri, S. B. Breitkopf, F. S. Oppermann, and H. Daub. 2010. Quantitative analysis of kinase-proximal signaling in lipopolysaccharide-induced innate immune response. J. Proteome Res. 9: 2539-2549.
35. Kishore, N., Q. K. Huynh, S. Mathialagan, T. Hall, S. Rouw, D. Creely, G. Lange, J. Caroll, B. Reitz, A. Donnelly, et al. 2002. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J. Biol. Chem. 277: 13840-13847.
36. Zhang, L., X. Zhao, M. Zhang, W. Zhao, and C. Gao. 2014. Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANK-binding kinase 1. J. Immunol. 193: 2230-2237.
37. Friedman, C. S., M. A. O'Donnell, D. Legarda-Addison, A. Ng, W. B. Cárdenas, J. S. Yount, T. M. Moran, C. F. Basler, A. Komuro, C. M. Horvath, et al. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9: 930-936.
38. Zhao, Y., L. Liang, Y. Fan, S. Sun, L. An, Z. Shi, J. Cheng, W. Jia, W. Sun, Y. Mori-Akiyama, et al. 2012. PPM1B negatively regulates antiviral response via dephosphorylating TBK1. Cell. Signal. 24: 2197-2204.
39. Long, L., Y. Deng, F. Yao, D. Guan, Y. Feng, H. Jiang, X. Li, P. Hu, X. Lu, H. Wang, et al. 2014. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 40: 515-529.
40. Negishi, H., K. Matsuki, N. Endo, H. Sarashina, S. Miki, A. Matsuda, K. Fukazawa, N. Taguchi-Atarashi, H. Ikushima, H. Yanai, et al. 2013. Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis. Proc. Natl. Acad. Sci. USA 110: 19884-19889.
41. Rajsbaum, R., R. A. Albrecht, M. K. Wang, N. P. Maharaj, G. A. Versteeg, E. Nistal-Villán, A. García-Sastre, and M. U. Gack. 2012. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog. 8: e1003059.
42. Li, K., E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon, M. Ikeda, S. C. Ray, M. Gale, Jr., and S. M. Lemon. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102: 2992-2997.
43. Ding, Q., X. Cao, J. Lu, B. Huang, Y. J. Liu, N. Kato, H. B. Shu, and J. Zhong. 2013. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J. Hepatol. 59: 52-58.
44. Nitta, S., N. Sakamoto, M. Nakagawa, S. Kakinuma, K. Mishima, A. Kusano-Kitazume, K. Kiyohashi, M. Murakawa, Y. Nishimura-Sakurai, S. Azuma, et al. 2013. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology 57: 46-58.
45. Li, X. D., L. Sun, R. B. Seth, G. Pineda, and Z. J. Chen. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102: 17717-17722.
46. Yan, N., A. D. Regalado-Magdos, B. Stiggelbout, M. A. Lee-Kirsch, and J. Lieberman. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11: 1005-1013.
47. Laguette, N., B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
48. Meggio, F., and L. A. Pinna. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17: 349-368.
49. Cozza, G., L. A. Pinna, and S. Moro. 2013. Kinase CK2 inhibition: an update. Curr. Med. Chem. 20: 671-693.
50. Sarno, S., H. Reddy, F. Meggio, M. Ruzzene, S. P. Davies, A. Donella-Deana, D. Shugar, and L. A. Pinna. 2001. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett. 496: 44-48.
51. Brown, M. S., O. T. Diallo, M. Hu, R. Ehsanian, X. Yang, P. Arun, H. Lu, V. Korman, G. Unger, K. Ahmed, et al. 2010. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules. Clin. Cancer Res. 16: 2295-2307.
52. Jaksch, C., and P. Thams. 2014. A critical role for CK2 in cytokine-induced activation of NFκB in pancreatic β cell death. Endocrine 47: 117-128.
53. Shen, J., P. Channavajhala, D. C. Seldin, and G. E. Sonenshein. 2001. Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha. J. Immunol. 167: 4919-4925.
54. Sun, Z., H. Ren, Y. Liu, J. L. Teeling, and J. Gu. 2011. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85: 1036-1047.
55. Li, B., A. Samanta, X. Song, K. T. Iacono, K. Bembas, R. Tao, S. Basu, J. L. Riley, W. W. Hancock, Y. Shen, et al. 2007. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 104: 4571-4576.
56. Wang, L., L. Zhang, X. Zhao, M. Zhang, W. Zhao, and C. Gao. 2013. Lithium attenuates IFN-β production and antiviral response via inhibition of TANK-binding kinase 1 kinase activity. J. Immunol. 191: 4392-4398.
57. Dulbecco, R., and M. Vogt. 1953. Some problems of animal virology as studied by the plaque technique. Cold Spring Harb. Symp. Quant. Biol. 18: 273-279.
58. Yi, M. 2010. Hepatitis C virus: propagation, quantification, and storage. Curr. Protoc. Microbiol. Chapter 15:Unit 15D.1.
59. Landesman-Bollag, E., A. Belkina, B. Hovey, E. Connors, C. Cox, and D. C. Seldin. 2011. Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Mol. Cell. Biochem. 356: 227-231.
60. Xu, X., P. A. Toselli, L. D. Russell, and D. C. Seldin. 1999. Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat. Genet. 23: 118-121.
61. Lafaille, F. G., I. M. Pessach, S. Y. Zhang, M. J. Ciancanelli, M. Herman, A. Abhyankar, S. W. Ying, S. Keros, P. A. Goldstein, G. Mostoslavsky, et al. 2012. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491: 769-773.
62. Pérez de Diego, R., V. Sancho-Shimizu, L. Lorenzo, A. Puel, S. Plancoulaine, C. Picard, M. Herman, A. Cardon, A. Durandy, J. Bustamante, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33: 400-411.
63. Gao, P., M. Ascano, T. Zillinger, W. Wang, P. Dai, A. A. Serganov, B. L. Gaffney, S. Shuman, R. A. Jones, L. Deng, et al. 2013. Structure-function analysis of STING activation by c[G(2′,5′)pA(3′,5′)p] and targeting by antiviral DMXAA. Cell 154: 748-762.
64. Conlon, J., D. L. Burdette, S. Sharma, N. Bhat, M. Thompson, Z. Jiang, V. A. Rathinam, B. Monks, T. Jin, T. S. Xiao, et al. 2013. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J. Immunol. 190: 5216-5225.
65. Bian, Y., M. Ye, C. Wang, K. Cheng, C. Song, M. Dong, Y. Pan, H. Qin, and H. Zou. 2013. Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow. Sci. Rep. 3: 3460.
66. Sumpter, R., Jr., Y. M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79: 2689-2699.
67. Pérez, M., and J. Avila. 1999. The expression of casein kinase 2alpha' and phosphatase 2A activity. Biochim. Biophys. Acta 1449: 150-156.
68. Koffa, M. D., J. Kean, G. Zachos, S. A. Rice, and J. B. Clements. 2003. CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 protein. J. Virol. 77: 4315-4325.
69. Wang, P., Y. Bai, B. Song, Y. Wang, D. Liu, Y. Lai, X. Bi, and Z. Yuan. 2011. PP1A-mediated dephosphorylation positively regulates YAP2 activity. PLoS One 6: e24288.